Total Funding
83
25
Total FundingSeed raised
Growth Score 83 in past quarter
-6 pts
Heat Score 25 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
972132
Axxia Pharmaceuticals provides implantable polymeric drug delivery technologies.
- Wayne C. Pollock: COO, General Manager & Partner
About the Company
Axxia Pharmaceuticals, Inc., a specialty pharmaceutical company, provides implantable polymeric drug delivery technologies. Its solutions include a non-inflammatory, biocompatible, and subcutaneous polymeric implant for the controlled release of hydromorphone with zero-order kinetics for treatment of moderate to severe chronic pain. The company
offers its hydromorphone implant for treating cancer patients. Axxia Pharmaceuticals, Inc. was incorporated in 1998 and is based in Bel Air, Maryland.
